Bard PowerPort Lawsuit

If you have experienced complications following the implantation of a Bard PowerPort, it is important to understand that a medical complication does not automatically establish a viable lawsuit. A potential claim generally requires documented proof of the specific Bard implanted-port model, a detailed implantation and removal history, evidence of a device failure or specific injury, and a clear medical link between the device and the harm caused. Furthermore, the claim must be supported by an actionable legal theory—such as a design or manufacturing defect—and be filed within the applicable statute of limitations.

Currently, these individual claims are being coordinated in MDL 3081 (In re: Bard Implanted Port Catheter Products Liability Litigation). As of the Judicial Panel on Multidistrict Litigation (JPML) October 1, 2026 report, there are 4,140 pending actions and 4,420 total historical actions centralized in the District of Arizona before Judge David G. Campbell. While often confused with a class action, an MDL coordinates individual cases for pretrial efficiency; each plaintiff must still prove their own specific damages and causation.

Recent Litigation Status and Bellwether Trials

Bellwether trials are used to test legal theories and jury reactions to evidence. Their results do not automatically decide other cases but can influence future settlement discussions.

• The Cook Verdict (May 2026): The first bellwether trial, Cook v. Becton Dickinson, resulted in a defense verdict on two claims and a mistrial on two other claims, according to BD's SEC filing.
• The Divelbliss Verdict (September 4, 2026): The second bellwether trial resulted in a $40 million compensatory verdict for the plaintiff. The jury found the defendants liable for design-defect and failure-to-warn claims, though no punitive damages were awarded. According to trial counsel reports, this verdict represents a specific jury finding for one individual and is not a universal valuation benchmark or settlement offer for other claimants.
• Next Scheduled Trial: According to Case Management Order (CMO) 38, the next bellwether trial is scheduled to begin on October 13, 2026.

Do you potentially have a Bard implanted-port claim?

A practical claim screening review considers five primary factors:

1. Device Identification: Can you prove the device was a Bard PowerPort? This requires an implant card or surgical records showing the model and lot number.
2. Documented Failure: Did the device fracture, migrate, or cause a severe infection?
3. Physical Injury: Is there a documented medical injury, such as an embolism, organ perforation, or thrombosis?
4. Causation: Can medical experts link the injury specifically to a defect in the device rather than an alternative medical cause?
5. Timeliness: Does the claim comply with the statute of limitations in your specific state?

[bard_long_1]

What products and alleged failures are involved?

The litigation involves various models of Bard PowerPort devices, which are implantable ports used to deliver medication (like chemotherapy) into the bloodstream. These devices consist of a reservoir (the port) and a catheter tube.

According to JPML transfer order descriptions, plaintiffs allege that the catheters are defectively designed because they contain high concentrations of barium sulfate. They claim that this material leads to surface irregularities and degradation, causing the catheter to lose its structural integrity.

Alleged failures include:

• Catheter Fracture: The tube breaks into pieces that travel through the bloodstream.
• Migration: The device or its components move from the original implant site.
• Infection and Clotting: Surface degradation may encourage bacterial growth or the formation of blood clots (thrombosis).

What evidence matters most?

To build a case, claimants need evidence that connects the identified device, alleged failure, injury, and resulting losses.

Evidence Checklist

• Product ID: Implant card, operative reports, UDI (Unique Device Identifier), and manufacturer labels.
• Surgical Records: Records for both the initial implantation and the subsequent removal (explant) surgery.
• Device Preservation: If the port was removed, the physical device itself is a critical piece of evidence.
• Imaging: X-rays, CT scans, or ultrasounds showing device fracture or migration.
• Medical Causation: Pathology reports, treating-physician notes, and infection cultures.
• Damages: Records of medical expenses, lost income, and documentation of lasting physical impairment.

Recall Status

It is a common misconception that all Bard PowerPorts have been recalled. While there have been limited, lot-specific recalls, they do not cover all devices involved in the MDL.

• Recall Z-1572-2020: Involved specific lots due to incorrect tunneler tips (FDA source).
• Recall Z-1551-2021: Involved specific PowerPort duo MRI lots after reports of difficulty flushing, infusing, or aspirating and septum dislodgement (FDA source).

These limited recalls were not blanket recalls proving the central design-defect allegations currently being litigated in the MDL.

[justice_short_1]

Potential Compensation Factors

Compensation in a successful claim is based on individual damages. While the $40 million Divelbliss verdict is a significant data point, it does not guarantee a similar payout for others. Factors include:

• Severity of Injury: Life-threatening events like a pulmonary embolism generally carry more weight than minor complications.
• Revision Surgery: The necessity and complexity of the surgery to remove or replace the device.
• Permanency: Whether the injury caused lasting disability or chronic health issues.
• Economic Loss: Total medical bills and lost wages.
• Jurisdiction: The specific state laws where the case is filed, which impact available damages and defenses.

When a complication may not support a lawsuit

Not every bad outcome results in a viable legal claim. A lawsuit may not be sustainable if:

• Different Manufacturer: The port was made by a company other than Bard.
• Alternative Cause: The complication was a known risk of the underlying medical condition or a result of improper surgical technique rather than a device defect.
• Minimal Damages: The complication was minor and resolved quickly without significant medical intervention.
• Statute of Limitations: The legal deadline to file has already passed.
• Lack of Evidence: The device was discarded, and imaging does not show a clear failure mechanism.

Deadlines and Next Steps

There is no single deadline for all Bard PowerPort claims. The time limit to file depends on state law, the date of the injury, the date the device was removed, and any applicable discovery rule concerning when the claimant knew or should have known of a potential connection.

If you suspect your port failed, the first step is to request your medical records and contact a law firm that specializes in medical device litigation to review your specific timeline.

Timeline of Key Events

• October 1, 2026: The JPML reports 4,140 pending actions and 4,420 total historical actions in MDL 3081.
• September 4, 2026: A jury awards $40 million in compensatory damages in the Divelbliss bellwether trial for design-defect and failure-to-warn claims, according to the trial-team report.
• July 22, 2026: The court denies the defendants' motion for summary judgment in the Divelbliss case, allowing the remaining claims to proceed to a jury trial without deciding liability at that stage.
• May 8, 2026: The first bellwether trial, Cook, ends in a defense verdict on two claims and a mistrial on two others, a result later reported in BD's SEC filing.
• August 8, 2023: The Judicial Panel on Multidistrict Litigation centralizes the litigation in the District of Arizona as MDL 3081.

Bard PowerPort FAQ

Is the Bard PowerPort lawsuit a class action? No. It is a Multidistrict Litigation (MDL). In a class action, one representative case decides the outcome for everyone. In an MDL, cases are grouped for discovery, but each plaintiff must prove their own specific injuries to receive compensation.

How many lawsuits have been filed? As of October 1, 2026, there are 4,140 pending cases in MDL 3081.

What is the average settlement for a Bard PowerPort? The reviewed sources do not establish an average settlement. The litigation is in the bellwether-trial phase, and the $40 million Divelbliss result was one jury verdict rather than a settlement or a valuation rule for other claims.

Has the FDA recalled all Bard PowerPorts? No blanket recall of every Bard PowerPort is shown in the FDA records reviewed here. The cited FDA entries concern limited models and lots with specific identified problems.

What records should I collect? Important records include the implant card, the operative report from the implantation, any removal or revision records, and imaging such as X-rays or CT scans taken when the complication was evaluated.

Legal.com Liability Disclaimer

All content published by Legal.com is provided for general informational purposes only. It is not legal advice, does not constitute a legal opinion, and should not be relied upon as a substitute for consultation with a qualified attorney. No attorney-client relationship is created by reading this article, using Legal.com templates, or contacting Legal.com. Legal.com disclaims all liability for actions taken or not taken based on this publication.